Authors:
TAN J
CRUCIAN BE
CHANG AE
ARUGA E
ARUGA A
DOVHEY SE
TANIGAWA K
YU H
Citation: J. Tan et al., INTERFERON-GAMMA-INDUCING FACTOR ELICITS ANTITUMOR IMMUNITY IN ASSOCIATION WITH INTERFERON-GAMMA PRODUCTION, Journal of immunotherapy, 21(1), 1998, pp. 48-55
Authors:
COUGHLIN CM
SALHANY KE
WYSOCKA M
ARUGA E
KURZAWA H
CHANG AE
HUNTER CA
FOX JC
TRINCHIERI G
LEE WMF
Citation: Cm. Coughlin et al., INTERLEUKIN-12 AND INTERLEUKIN-18 SYNERGISTICALLY INDUCE MURINE TUMOR-REGRESSION WHICH INVOLVES INHIBITION OF ANGIOGENESIS, The Journal of clinical investigation, 101(6), 1998, pp. 1441-1452
Authors:
KURZAWA H
WYSOCKA M
ARUGA E
CHANG AE
TRINCHIERI G
LEE WMF
Citation: H. Kurzawa et al., RECOMBINANT INTERLEUKIN-12 ENHANCES CELLULAR IMMUNE-RESPONSES TO VACCINATION ONLY AFTER A PERIOD OF SUPPRESSION, Cancer research, 58(3), 1998, pp. 491-499
Authors:
ARUGA E
ARUGA A
ARCA MJ
LEE WMF
YANG NS
SMITH JW
CHANG AE
Citation: E. Aruga et al., IMMUNE RESPONSIVENESS TO A MURINE MAMMARY-CARCINOMA MODIFIED TO EXPRESS B7-1, INTERLEUKIN-12, OR GM-CSF, Cancer gene therapy, 4(3), 1997, pp. 157-166
Citation: A. Aruga et al., DIFFERENT CYTOKINE PROFILES RELEASED BY CD4(-DRAINING LYMPH-NODE CELLS INVOLVED IN MEDIATING TUMOR-REGRESSION() AND CD8(+) TUMOR), Journal of leukocyte biology, 61(4), 1997, pp. 507-516
Authors:
ARUGA A
ARUGA E
TANIGAWA K
BISHOP DK
SONDAK VK
CHANG AE
Citation: A. Aruga et al., TYPE-1 VERSUS TYPE-2 CYTOKINE RELEASE BY V-BETA T-CELL SUBPOPULATIONSDETERMINES IN-VIVO ANTITUMOR REACTIVITY - IL-10 MEDIATES A SUPPRESSIVE ROLE, The Journal of immunology, 159(2), 1997, pp. 664-673
Citation: A. Aruga et al., REDUCED EFFICACY OF ALLOGENEIC VERSUS SYNGENEIC FIBROBLASTS MODIFIED TO SECRETE CYTOKINES AS A TUMOR VACCINE ADJUVANT, Cancer research, 57(15), 1997, pp. 3230-3237
Citation: E. Aruga et al., MACROMOLECULES THAT ARE COLOCALIZED WITH DEPOSITS OF BETA-2-MICROGLOBULIN IN HEMODIALYSIS-ASSOCIATED AMYLOIDOSIS, Laboratory investigation, 69(2), 1993, pp. 223-230